Hongli Xu

机构：Hubei Provincial Center for Disease Control and Prevention, Center for Cancer Research, Hubei Cancer Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-6905-5729

发表论文 69 篇 · 总被引 767 次 · h-index 17

代表论文

• Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors (2022 · BMC Cancer · 被引 70)
• Male‐Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development (2023 · Advanced Science · 被引 51)
• Black rice diet alleviates colorectal cancer development through modulating tryptophan metabolism and activating AHR pathway (2024 · iMeta · 被引 37)
• Manganese Dioxide/Gold-based Active Tumor Targeting Nanoprobes for Enhancing Photodynamic and Low-Temperature-Photothermal Combination Therapy in Lung Cancer (2023 · ACS Applied Materials & Interfaces · 被引 24)
• Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection (2022 · BMC Gastroenterology · 被引 12)
• Experimental investigation on evaporative cooling coupled phase change energy storage technology for data centers under natural air cooling (2024 · International Communications in Heat and Mass Transfer · 被引 9)